Patrizio Bina
Overview
Explore the profile of Patrizio Bina including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
220
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Derchi G, Dessi C, Bina P, Cappellini M, Piga A, Perrotta S, et al.
Intern Emerg Med
. 2018 Jun;
14(3):365-370.
PMID: 29948832
Heart disease remains a leading cause of morbidity and mortality in transfusion-dependent thalassemia (TDT), which can be attributed to several factors but primarily develops in the setting of iron overload....
2.
Dessi C, Leoni G, Moi P, Danjou F, Follesa I, Foschini M, et al.
Blood Cells Mol Dis
. 2015 May;
55(1):82-8.
PMID: 25976473
The aim of the study was to assess the current state in terms of liver and heart iron overload as well as of liver and heart related morbidity and mortality...
3.
Derchi G, Balocco M, Bina P, Caruso V, DAscola D, Littera R, et al.
Haematologica
. 2014 Feb;
99(2):e17-8.
PMID: 24497563
No abstract available.
4.
Derchi G, Galanello R, Bina P, Cappellini M, Piga A, Lai M, et al.
Circulation
. 2013 Oct;
129(3):338-45.
PMID: 24081970
Background: Pulmonary arterial hypertension (PAH) remains a concern in patients with β-thalassemia major (TM) and intermedia (TI); however, studies evaluating its prevalence and risk factors using systematic confirmation on right...
5.
Origa R, Danjou F, Cossa S, Matta G, Bina P, Dessi C, et al.
Br J Haematol
. 2013 Sep;
163(3):400-3.
PMID: 24033185
This study aimed to verify the impact of heart magnetic resonance imaging on chelation choices and patient compliance in a single-institution cohort as well as its predictive value for heart...
6.
Derchi G, Formisano F, Balocco M, Galanello R, Bina P, Dessi C, et al.
Eur J Echocardiogr
. 2011 Feb;
12(3):242-6.
PMID: 21278193
Aims: To determine the clinical management of cardiovascular complications, and the extent of cardiac left ventricular (LV) involvement, in a large cohort of homogenously treated patients with thalassaemia major. Methods...
7.
Lai M, Grady R, Vacquer S, Pepe A, Carta M, Bina P, et al.
Blood Cells Mol Dis
. 2010 Aug;
45(2):136-9.
PMID: 20678715
Myocardial iron overload is the leading cause of death in patients with beta-thalassemia major. An intensification monotherapy with deferoxamine (DFO) as well as a combination therapy with DFO and deferiprone...
8.
Origa R, Barella S, Argiolas G, Bina P, Agus A, Galanello R
Haematologica
. 2008 May;
93(7):1095-6.
PMID: 18508795
No abstract available.
9.
Cogliandro T, Derchi G, Mancuso L, Mayer M, Pannone B, Pepe A, et al.
J Cardiovasc Med (Hagerstown)
. 2008 Apr;
9(5):515-25.
PMID: 18404006
Thalassemia major is an inherited hemoglobin disorder resulting in a chronic hemolytic anemia. Transfusion therapy together with elevated gastrointestinal absorption of iron determines iron overload, which causes most of the...
10.
Origa R, Bina P, Agus A, Crobu G, Defraia E, Dessi C, et al.
Haematologica
. 2005 Oct;
90(10):1309-14.
PMID: 16219566
Background And Objectives: Effective and convenient iron chelation remains one of the main targets of clinical management of thalassemia major. The combined treatment with desferrioxamine and deferiprone could have an...